BioElectronics Responds to U.S. FDA’s Comments on its Market Clearance Application

FREDERICK, Md., May 10, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices, announced that it remains in negotiations with the U.S. Food and Drug Administration (“FDA”) regarding its  510(k) premarket notification for the ActiPatch® Musculoskeletal Pain Therapy. Two weeks ago, it submitted detailed responses to the FDA’s questions related to the […]

BioElectronics’ Drug-free ActiPatch® Pain Therapy Highlighted in UK’s Express Newspaper on Dangers of Excessive Drug Use

FREDERICK, Md., April 28, 2016 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its drug-free ActiPatch® product  was noted in the United Kingdom’s Express Newspaper Health Section,  http://www.express.co.uk/life-style/health/664330/arthritis-pain-pills-warning-sufferers-taking-too-many-drugs-fight-agony.  The paper has a circulation of 400,000 that will increase the awareness of ActiPatch therapy for arthritis and chronic pain. The […]

BioElectronics’ ActiPatch® Chronic Pain Therapy Featured In UK’s Leading Daily Mail Newspaper Health Section

BioElectronics’ ActiPatch® Chronic Pain Therapy Featured In UK’s Leading Daily Mail Newspaper Health Section FREDERICK, MD, USA, March 29, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its ActiPatch® product’s were featured in the United Kingdom’s leading Daily Mail’s Sunday Health Section, http://www.dailymail.co.uk/health/article-3555221/The-20-pulsing-skin-patch-end-misery-chronic-pain-arthritis-sufferers-diabetics.html. […]

BioElectronics President Interviewed by the StockRadio.com

Discusses Bioelectronics Mitigation of Chronic Pain and Drug Use BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, is pleased to release an interview with President, Andy Whelan. The interview can be heard at http://thestockradio.com/andrew-whelan-bioelectronics-corp-biel-2953.html Mr. Whelan explained the science of bioelectronics, the chronic pain market, the far-reaching […]

BioElectronics Appoints Evomed as Australian and New Zealand Distributor

FREDERICK, MD. March 21, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that it has appointed Evomed (www.evomed.com.au) as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole™ Heel Pain Relief Therapy in Australia and New Zealand. Evomed specializes in the […]

BioElectronics Wins “Best OTC Marketing Campaign on a Small Budget”

FREDERICK, MD. March 15, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen its ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the “Best OTC Marketing Campaign on a Small Budget” award. […]

BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress

FREDERICK, MD, USA, March 9, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that a research abstract featuring ActiPatch® will be presented at the British Pain Society annual scientific meeting being held from May 10-12 in Harrogate, UK https://www.britishpainsociety.org/2016-asm/. The Company will also be exhibiting at the […]